Officer sold
~$1.11MReported value · 9,233 sh @ $120.50
Stock since the trade −6.3% · S&P 500 +2.3% · to Oct 5
Incyte's President, Global Head of R&D sold $1.11M of Incyte shares. Nobody planned it ahead of time.
Loading…
INCY · NASDAQ · Biotechnology
Stock since the trade −6.3% · S&P 500 +2.3% · to Oct 5
Incyte's President, Global Head of R&D sold $1.11M of Incyte shares. Nobody planned it ahead of time.
Officer sold ~$1.69M of Incyte
Automatic saleOfficer plans to sell ~$2.8M of Incyte
Planned, from payOfficer sold ~$1.36M of Incyte
Automatic saleOfficer sold ~$1.31M of Incyte
Automatic salePatrick A Mayes · Traded Jul 31, 2026 · largest single filing ~$1.75M
Jul 31, 2026~$1.75M · 15K sh @ $119.46
DetailsOfficial recordJul 31, 2026~$737K · 6,171 sh @ $119.43
DetailsPatrick A Mayes · Traded Jul 31, 2026 · largest single filing ~$40K
Jul 31, 2026~$40K · 326 sh @ $121.69
DetailsOfficial recordJul 31, 2026~$10K · 85 sh @ $122.19
DetailsOfficial recordStock since the trade −2.2% · S&P 500 +3.2% · to Oct 5
Incyte's CMO & Head of Late-Stage Dev. sold $215K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade −2.2% · S&P 500 +3.2% · to Oct 5
Incyte's Head of U.S. Commercial sold $126K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade −0.8% · S&P 500 +2.6% · to Oct 5
Incyte's CMO & Head of Late-Stage Dev. sold $3.19M of Incyte shares. Nobody planned it ahead of time.
Director sold ~$1.42M of Incyte
Automatic saleOfficer sold ~$1.76M of Incyte
Automatic saleOfficer sold ~$1.88M of Incyte
Automatic saleOfficer sold ~$1.18M of Incyte
Automatic saleOfficer sold ~$1.59M of Incyte
Automatic saleStock since the trade +17.3% · S&P 500 +14.5% · to Oct 5
Incyte's Principal Accounting Officer sold $59K of Incyte shares. Nobody planned it ahead of time.
Michael James Morrissey · Traded Dec 16, 2025 · largest single filing ~$5.17M
Dec 16, 2025~$5.17M · 53K sh @ $97.29
DetailsOfficial recordDec 16, 2025~$81K · 833 sh @ $97.42
DetailsOfficial recordStock since the trade +19.9% · S&P 500 +12.7% · to Oct 5
Incyte's & Chief Scientific Officer sold $531K of Incyte shares. Nobody planned it ahead of time.
Stock since the trade +11.8% · S&P 500 +13.9% · to Oct 5
Incyte's & Chief Medical Officer sold $263K of Incyte shares. Nobody planned it ahead of time.
Officer sold ~$2.06M of Incyte
Automatic saleJul 31, 2026~$637K · 5,332 sh @ $119.42
DetailsOfficial recordJul 31, 2026~$561K · 4,695 sh @ $119.39
DetailsOfficial recordJul 31, 2026~$342K · 2,864 sh @ $119.40
DetailsOfficial recordJul 31, 2026~$274K · 2,293 sh @ $119.41
DetailsOfficial recordJul 31, 2026~$261K · 2,187 sh @ $119.47
DetailsOfficial recordJul 31, 2026~$196K · 1,643 sh @ $119.51
DetailsOfficial recordJul 31, 2026~$196K · 1,642 sh @ $119.38
DetailsOfficial record